Aisling Capital vs Frazier Life Sciences
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| Aisling Capital | Frazier Life Sciences | |
|---|---|---|
| Type | Venture capital | Crossover fund |
| HQ | New York | Palo Alto |
| Founded | 2000 | 2015 |
| Stages | Seed, Series A, Series B, Series C | Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Digital Health, Healthtech, Medical Devices | Biotech |
| AUM | $716.4M | $7B |
| Tracked investments | 119 | 141 |
| Exits (acquired/public) | 1 | 4 |
| Dated deals, last 24 mo | 2 | 1 |
Shared portfolio · 7
BridgebioChimerix NASDAQ: CMRX www.chimerix.comCidara TherapeuticsCV TherapeuticsGondolabioVerona PharmaVivus
Frequently asked questions
- Do Aisling Capital and Frazier Life Sciences invest together?
- Yes — Aisling Capital and Frazier Life Sciences appear together in 7 tracked portfolio companies, including Bridgebio, Chimerix NASDAQ: CMRX www.chimerix.com, Cidara Therapeutics, CV Therapeutics, Gondolabio.